Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 9486512 In situ antigen-generating cancer vaccine

Patent 9486512 was granted and assigned to President and Fellows of Harvard College on November, 2016 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

‌

President and Fellows of Harvard College

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

9486512

Date of Patent

November 8, 2016

Patent Application Number

14123615

Date Filed

June 4, 2012

Patent Citations Received

‌

US Patent 11786457 Peritumoral and intratumoral materials for cancer therapy

‌

US Patent 11998593 Combination vaccine devices and methods of killing cancer cells

‌

US Patent 11944837 System and methods for treating cancer cells with alternating polarity magnetic fields

‌

US Patent 11752238 Recapitulating the hematopoietic niche to reconstitute immunity

‌

US Patent 11931593 System and methods for treating cancer cells with alternating polarity magnetic fields

Patent Primary Examiner

‌

Sean Aeder

Patent abstract

The invention provides compositions and methods for utilizing scaffolds in cancer vaccines.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 9486512 In situ antigen-generating cancer vaccine

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API